PRN: Global Blood Glucose Monitoring Devices Market to Grow at a CAGR of 11.8% by 2021 - Increased Adoption of Bundled Product Marketing Strategy - Research and Markets

24/mar/2017 14:30:15 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Blood Glucose Monitoring Devices Market to Grow at a CAGR of 11.8% by 2021 - Increased Adoption of Bundled Product Marketing Strategy - Research and Markets


DUBLIN, Mar 24, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Blood Glucose Monitoring Devices Market 2017-2021" report to their offering.

Research and Markets Logo

The global blood glucose monitoring devices market to grow at a CAGR of 11.81% during the period 2017-2021.

The report, Global Blood Glucose Monitoring Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

One trend in market is smart watch-based apps. The Dexcom CGM and its mobile apps Follow and Share 2 are the first mobile-connected systems approved by the US FDA. This device allows users to directly view the glucose data on their iPhone. Currently, Dexcom provides its devices G4 platinum CGM with Share that supports the Apple watch. Along with this, the users can invite up to five people to view their glucose information, and an alert message can be sent when the user's glucose levels are above normal range. This is a significant breakthrough in diabetes management. The use of glucose meters is supplemented by CGM devices in diabetes management. Meters still play a major role in calibrating CGM devices and in guiding therapy and meal decisions. In addition to providing the glucose levels, CGM devices provide the direction and rate of change in glucose levels with the push of a button and alerts users when the glucose level is too low or too high.

According to the report, one driver in market is growing prevalence of diabetes in the world. In 2015, approximately 415 million people in the world had diabetes, which is expected to increase to around 642 million by 2040. As of 2015, it has been estimated that 9.1% adults in the world have diabetes and this is expected to increase to 10% by 2040. In addition, 75%-80% of the individuals with diabetes belonged to low- and middle-income countries. The number of people with diabetes is high in APAC. According to OECD, the prevalent cases are going to reach about 47,973,000 in Europe, 66,812,000 in the Americas, and 18,234,000 in Africa by 2030. The global prevalence of diabetes was estimated to be 9% among adults aged above 18 years.

Key vendors

  • Abbott Laboratories
  • Roche Diagnostics
  • LifeScan
  • Medtronic

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by product

PART 07: Market segmentation by end-user

PART 08: Geographical segmentation

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends
PART 14: Vendor landscape

PART 15: Key vendor analysis

PART 16: Appendix

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl